BioSpace News Archive

VieCure, Inc. today announced the closing of its $25 million Series A growth equity investment, led by Northpond Ventures. An undisclosed investor is also contributing to the round

LEXEO Therapeutics, a clinical-stage gene therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to LX1001, the company’s adeno-associated virus (AAV) mediated gene therapy program, for the potential treatment of apolipoprotein E4 (APOE4) associated Alzheimer’s disease

Shields Capital and KNR Therapy, a leader in Applied Behavior Analysis (ABA) that provides individualized treatment to children with Autism Spectrum Disorder (ASD), is proud to announce its recent merger with Forbes Behavioral Services

Today LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is launching No One Missed, a multi-year, integrated campaign to drive comprehensive biomarker testing in non-small cell lung cancer (NSCLC)—the most common type of lung cancer—to help people pursue optimal care

CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks, today announced it has joined the Microsoft Intelligent Security Association (MISA),

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced that during its Board meeting on March 11, 2021 , three new members were appointed to the Board of Directors — Melanie Bolch Isbill , Alex Krys and Jack Quinn.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced in association with the American Association of Endodontists (AAE) Annual Meeting beginning on April 21, 2021

TytoCare, the global healthcare industry’s first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, today announced the appointment of Tamir Gotfried as Chief Commercial Officer (CCO).

Mitsubishi Tanabe Pharma America, Inc. announced the presentation of an analysis of the timing of disease progression milestones among commercially insured amyotrophic lateral sclerosis patients treated with intravenous RADICAVA®.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused clinical-stage biopharmaceutical company, announced that its novel anti-cancer therapeutic exhibited highly positive results in humanized mast cell neoplasm models, representative in vitro and in vivo models for aggressive, mast cell-derived cancers such as mast cell leukemia and mast cell sarcoma.